LEVEL 4 J01DC04

Δραστικές

CEFACLOR

Φάρμακα

  • DRUGBANK - Cefaclor
  • indication:

    For the treatment of certain infections caused by bacteria such as pneumonia and ear, lung, skin, throat, and urinary tract infections.

  • pharmacology:

  • mechanism:

    Cefaclor, like the penicillins, is a beta-lactam antibiotic. By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, it inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins. It is possible that cefaclor interferes with an autolysin inhibitor.

  • toxicity:

    Symptoms of overdose include diarrhea, nausea, stomach upset, and vomiting.

  • absorprion:

    Well absorbed after oral administration, independent of food intake.

  • halflife:

    0.6-0.9 hour

  • roouteelimination:

    Approximately 60% to 85% of the drug is excreted unchanged in the urine within 8 hours, the greater portion being excreted within the first 2 hours.

  • volumedistribution:

  • clearance: